Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Enhanced detection of circulating tumor DNA by fragment size analysis.

Mouliere F, Chandrananda D, Piskorz AM, Moore EK, Morris J, Ahlborn LB, Mair R, Goranova T, Marass F, Heider K, Wan JCM, Supernat A, Hudecova I, Gounaris I, Ros S, Jimenez-Linan M, Garcia-Corbacho J, Patel K, Østrup O, Murphy S, Eldridge MD, Gale D, Stewart GD, Burge J, Cooper WN, van der Heijden MS, Massie CE, Watts C, Corrie P, Pacey S, Brindle KM, Baird RD, Mau-Sørensen M, Parkinson CA, Smith CG, Brenton JD, Rosenfeld N.

Sci Transl Med. 2018 Nov 7;10(466). pii: eaat4921. doi: 10.1126/scitranslmed.aat4921.

PMID:
30404863
2.

Copy number signatures and mutational processes in ovarian carcinoma.

Macintyre G, Goranova TE, De Silva D, Ennis D, Piskorz AM, Eldridge M, Sie D, Lewsley LA, Hanif A, Wilson C, Dowson S, Glasspool RM, Lockley M, Brockbank E, Montes A, Walther A, Sundar S, Edmondson R, Hall GD, Clamp A, Gourley C, Hall M, Fotopoulou C, Gabra H, Paul J, Supernat A, Millan D, Hoyle A, Bryson G, Nourse C, Mincarelli L, Sanchez LN, Ylstra B, Jimenez-Linan M, Moore L, Hofmann O, Markowetz F, McNeish IA, Brenton JD.

Nat Genet. 2018 Sep;50(9):1262-1270. doi: 10.1038/s41588-018-0179-8. Epub 2018 Aug 13.

PMID:
30104763
3.

MiR-192 and miR-662 enhance chemoresistance and invasiveness of squamous cell lung carcinoma.

Filipska M, Skrzypski M, Czetyrbok K, Stokowy T, Stasiłojć G, Supernat A, Jassem J, Żaczek AJ, Bigda J.

Lung Cancer. 2018 Apr;118:111-118. doi: 10.1016/j.lungcan.2018.02.002. Epub 2018 Feb 6.

PMID:
29571988
4.

Interactions between FGFR2 and RSK2-implications for breast cancer prognosis.

Czaplinska D, Mieczkowski K, Supernat A, Skladanowski AC, Kordek R, Biernat W, Zaczek AJ, Romanska HM, Sadej R.

Tumour Biol. 2016 Oct;37(10):13721-13731. Epub 2016 Jul 30.

5.

Rak błony śluzowej trzonu macicy u chorych po przebytej chorobie nowotworowej - aspekty kliniczne i molekularne.

Łapińska-Szumczyk SM, Supernat AM, Żaczek AJ, Majewska H, Gulczyński J, Sawicki S, Biernat W, Wydra D.

Ginekol Pol. 2016;87(2):88-93. doi: 10.17772/gp/60559. No abstract available.

6.

Immunohistochemical characterisation of molecular subtypes in endometrial cancer.

Łapińska-Szumczyk SM, Supernat AM, Majewska HI, Gulczyński J, Biernat W, Wydra D, Żaczek AJ.

Int J Clin Exp Med. 2015 Nov 15;8(11):21981-90. eCollection 2015.

7.

HOTAIR in relation to epithelial-mesenchymal transition and cancer stem cells in molecular subtypes of endometrial cancer.

Łuczak A, Supernat A, Łapińska-Szumczyk S, Jachimowicz D, Majewska H, Gulczyński J, Żaczek AJ.

Int J Biol Markers. 2016 Jul 30;31(3):e245-51. doi: 10.5301/jbm.5000187.

PMID:
26868332
8.

[Endometrial cancer in young women--clinical and molecular aspects].

Lapińska-Szumczyk S, Supernat A, Żaczek AJ, Majewska H, Gulczyński J, Sawicki S, Biernat W, Wydra D.

Ginekol Pol. 2014 Oct;85(10):754-9. Polish.

PMID:
25546926
9.

HER2-positive endometrial cancer subtype carries poor prognosis.

Lapińska-Szumczyk S, Supernat A, Majewska H, Gulczyński J, Luczak A, Biernat W, Wydra D, Zaczek AJ.

Clin Transl Sci. 2014 Dec;7(6):482-8. doi: 10.1111/cts.12207. Epub 2014 Sep 9.

10.

Tumor heterogeneity at protein level as an independent prognostic factor in endometrial cancer.

Supernat A, Lapińska-Szumczyk S, Majewska H, Gulczyński J, Biernat W, Wydra D, Zaczek AJ.

Transl Oncol. 2014 Oct;7(5):613-9. doi: 10.1016/j.tranon.2014.06.001. Epub 2014 Jul 19.

11.

A multimarker qPCR platform for the characterisation of endometrial cancer.

Supernat A, Łapińska-Szumczyk S, Majewska H, Gulczyński J, Biernat W, Wydra D, Zaczek AJ.

Oncol Rep. 2014 Feb;31(2):1003-13. doi: 10.3892/or.2013.2924. Epub 2013 Dec 13.

PMID:
24337234
12.

Epithelial-mesenchymal transition and cancer stem cells in endometrial cancer.

Supernat A, Lapinska-Szumczyk S, Majewska H, Gulczynski J, Biernat W, Wydra D, Zaczek AJ.

Anticancer Res. 2013 Dec;33(12):5461-9.

PMID:
24324082
13.

Deregulation of RAD21 and RUNX1 expression in endometrial cancer.

Supernat A, Lapińska-Szumczyk S, Sawicki S, Wydra D, Biernat W, Zaczek AJ.

Oncol Lett. 2012 Oct;4(4):727-732. Epub 2012 Jul 9.

14.

CD73 expression as a potential marker of good prognosis in breast carcinoma.

Supernat A, Markiewicz A, Welnicka-Jaskiewicz M, Seroczynska B, Skokowski J, Sejda A, Szade J, Czapiewski P, Biernat W, Zaczek A.

Appl Immunohistochem Mol Morphol. 2012 Mar;20(2):103-7.

PMID:
22553809
15.

Prognostic value of TOP2A gene amplification and chromosome 17 polysomy in early breast cancer.

Zaczek A, Markiewicz A, Supernat A, Bednarz-Knoll N, Brandt B, Seroczyńska B, Skokowski J, Szade J, Czapiewski P, Biernat W, Wełnicka-Jaśkiewicz M, Jassem J.

Pathol Oncol Res. 2012 Oct;18(4):885-94. Epub 2012 Mar 18.

PMID:
22426810

Supplemental Content

Loading ...
Support Center